Anti-VEGFR2 (Ab-1214) Antibody

This polyclonal primary antibody, raised in rabbit, recognizes VEGFR2 (vascular endothelial growth factor receptor 2), a type III receptor tyrosine kinase essential for VEGF-A–driven endothelial signaling and tumor angiogenesis. The unconjugated reagent is supplied by Antibodies.com as a 50 µl aliquot validated for western blot, immunohistochemistry, and immunofluorescence across human, mouse, and rat specimens. It targets an epitope in the C-terminal kinase region around residue 1214 of VEGFR2, supporting reproducible detection of endogenous receptor expression in tumor vasculature and primary endothelial cell cultures. For long-term use, the vial should be kept refrigerated and small aliquots prepared in advance to minimize freeze-thaw cycles and preserve polyclonal reactivity across multiple experiments.